Vaccines against SARS ‐CoV‐2 are safe to administer in patients with antibodies to pegaspargase

ConclusionSARS-CoV-2 vaccination is safe in this population.

Source: Cancer Medicine - July 15, 2022 Category: Cancer & Oncology Authors: Hope D. Swanson, Hana Hakim, Diego R. Hijano, Ted Morton, Shane Cross, Hiroto Inaba, Sima Jeha, Ching ‐Hon Pui, Seth E. Karol Tags: BRIEF COMMUNICATION Source Type: research